Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Pareesh Phulkar

Bookmark and Share
Combination Treatment In Aesthetics Market Growth Opportunities, Outlook, Analysis Forecast 2026
Increase in number of aging population worldwide, especially in developed economies is expected to drive growth of the combination treatment in aesthetics market.

Combination Treatment In, 9/13/2019 - Increase in number of aging population worldwide, especially in developed economies is expected to drive growth of the combination treatment in aesthetics market. According to the Plastic Surgery Statistics 2017, age group 40 to 54 contributed around 49% of the total cosmetic procedures in the U.S. This accounted to around 7.7 million cosmetic procedures, of which 7.1 million were minimally-invasive procedures. Furthermore, increase in disposable income of population in emerging economies such as China, India, and Brazil is major factor expected to fuel growth of the market.

Get PDF Brochure of This Business Report:

Combination treatment in aesthetic market in India is expected to witness significant growth due to medical tourism prospects in the country from cost competitiveness and skilled human resource in medical and cosmetic procedure sector. For instance, according to a data given by Ministry of External Affairs Of India, India issued over 0.17 million medical visas in 2016, compared to 0.12 million in 2015. According to the International Society of Aesthetic Plastic Surgery (ISAPS) report, in 2016, the top five countries – the U.S., Brazil, Japan, Italy, and Mexico – accounted for around 41.4% of the cosmetic procedures worldwide, followed by Russia, India, Turkey, Germany, and France.

Key players are launching innovative products in the market to expand their market share. These new products provide wide variety of device choices to physician that avail different combinations of minimum invasive devices with other modalities and efficient performance for various cosmetic treatments. For instance, In January 2018, Cutera, Inc. launched Juliet and Secret RF to its product offerings of laser and energy-based device. In the same year, Galderma S.A. was granted FDA approval for its next-generation hyaluronic acid (HA) dermal fillers – Restylane Refyne and Restylane Defyne – for the treatment of moderate to severe facial wrinkles and folds.

Market players are acquiring companies that could complement and add to product portfolio and expand geographical presence. In March 2017, Hologic, Inc. acquired Cynosure, Inc. —developer, manufacturer and supplier of a broad array of light-based aesthetic and medical treatment systems. In August 2018, Nestlé Skin Health – parent company for Galderma— announced acquisition of several key aesthetic dermatology products from Valeant Pharmaceuticals International, to commercialize in the U.S and Canada. Product acquired include, Restylane, Perlane and Emervel used for corrective facial aesthetic treatments, and Dysport, and Sculptra used in aesthetic dermatology treatment.

In April 2018, Merz GmbH launched its hyaluronic acid-based dermal filler product— Belotero Lips— for lip enhancement and treatment of perioral lines.

Browse more detail information about:

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.